|
|
According to experts, Umbilical cord banking technology has the potential for developing the correct stem cells which can be used for the treatment of diabetic ulcers, thereby preventing amputation.
"Umbilical cord banking technology has been found to produce proper stem cells to treat diabetic ulcer to avoid an amputation," CEO of Singapore-based Cordlife group Steven Fang said.
"Typically, diabetic ulcers are very difficult to heal, but with epithelial stem cells, ulcers can be healed within 45 days," he said.
According to him the epithelial stem cells are capable of rejuvenating skin as well as mucus membrane which can help in the treatment of non-healing wounds, especially the diabetic ulcers.
Umbilical cord banking technology has the potential for isolating two types of cells which will speed up the healing of general as well as diabetic foot ulcers. This also can help in healing injured tissues as well as organs.
"Our company is in the initial stage of identifying prominent institutions and specialist physicians to provide the application of epithelial stem cells on diabetics," he added.
Fang said that Cordlife, a stem cell banking leader, would provide the collection and storage of umbilical cord stem cells as a value-added service for all cord blood banking customers over a limited time.
